InspireMD Files 8-K

Ticker: NSPR · Form: 8-K · Filed: Dec 9, 2024 · CIK: 1433607

Inspiremd, INC. 8-K Filing Summary
FieldDetail
CompanyInspiremd, INC. (NSPR)
Form Type8-K
Filed DateDec 9, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, filing, company-update

TL;DR

InspireMD filed an 8-K on 12/9/24. Check it for updates.

AI Summary

InspireMD, Inc. filed an 8-K on December 9, 2024, reporting on other events and financial statements. The company, formerly Saguaro Resources, Inc., is incorporated in Delaware and headquartered in Miami, Florida.

Why It Matters

This filing provides an update on the company's activities and financial status, which is important for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, which typically reports on significant events but doesn't inherently indicate high risk.

Key Players & Entities

FAQ

What specific events are being reported in this 8-K filing?

The filing indicates it pertains to 'Regulation FD Disclosure', 'Other Events', and 'Financial Statements and Exhibits', but the specific details of these events are not provided in the excerpt.

When was the company formerly known as Saguaro Resources, Inc.?

The date of the name change from Saguaro Resources, Inc. to InspireMD, Inc. was April 28, 2008.

What is InspireMD, Inc.'s primary business classification?

InspireMD, Inc. is classified under 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]'.

Where are InspireMD, Inc.'s principal executive offices located?

The principal executive offices are located at 6303 Waterford District Drive, Suite 215, Miami, Florida 33126.

What is the SEC file number for InspireMD, Inc.?

The SEC file number for InspireMD, Inc. is 001-35731.

Filing Stats: 592 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-12-09 08:03:50

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: December 9, 2024 By: /s/ Craig Shore Name: Craig Shore Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing